Literature DB >> 16886702

[Patterns of non steroidal anti-inflammatory drug use in ambulatory care].

Stéphanie Lugardon1, Henri Roussel, Robert Bourrel, Vincent Sciortino, Jean-Louis Montastruc, Maryse Lapeyre-Mestre.   

Abstract

The aim of this study was to discuss the patterns of non steroidal anti-inflammatory drug (NSAID) use in general population. We identified NSAID's users from the French Health Insurance System claims database covering more of the population in the Midi-Pyrenees area (southwest of France), if they have received at least one NSAID in June 2003. We discussed this population according to the NSAID used, to their demographic characteristics and to other drugs delivered in the period. Our study shows different patterns of use according to each NSAID. For example, users of ibuprofen or tiaprofenic acid were younger and less frequently exposed to "gastroprotective" drugs, users of coxibs were older and more frequently exposed to drugs increasing the risk of bleeding. This study confirms the wide use of NSAIDs and describes their target population. It underlines the interest of Health Insurance System Database for better knowledge of drug use in ambulatory care in France.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16886702     DOI: 10.2515/therapie:2006029

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


  2 in total

1.  Laboratory monitoring of patients treated with antihypertensive drugs and newly exposed to non steroidal anti-inflammatory drugs: a cohort study.

Authors:  Jean-Pascal Fournier; Maryse Lapeyre-Mestre; Agnès Sommet; Julie Dupouy; Jean-Christophe Poutrain; Jean-Louis Montastruc
Journal:  PLoS One       Date:  2012-03-27       Impact factor: 3.240

2.  Use of nonsteroidal anti-inflammatory drugs and breast cancer risk in a prospective cohort of postmenopausal women.

Authors:  Manon Cairat; Marie Al Rahmoun; Marc J Gunter; Gianluca Severi; Laure Dossus; Agnès Fournier
Journal:  Breast Cancer Res       Date:  2020-10-31       Impact factor: 6.466

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.